MedPath

A clinical study on Aanmai kuraivu [Male Infertility]with trial drug Nerunjil vithai chooranam.

Phase 2
Active, not recruiting
Conditions
MALES WITH INFERTILITY
Registration Number
CTRI/2014/06/004646
Brief Summary

Nerunjil vithai chooranam is a polyherbal formulation, main ingredients are asparagus resemosus,mucuna pruriens,tribulus terrestris. In literature all ingredients of NVC have  aphrodisiac action. NVC is a safest and most effective for male infertility. 20 patients included in the trial and trial drug is given and monitered.

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Male
Target Recruitment
20
Inclusion Criteria

Oligospermia, Oligoasthenospermia, Willing to give semen for investigation.

Exclusion Criteria

Diabetes mellitus , Hypertension, Cardiac diseases, Hydrocele, Azoospermia, Vericocele.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Semen Analysis is done before and after treatment.After 48 days of treatment semen analysis is repeated.
Secondary Outcome Measures
NameTimeMethod
LFT and RFT is measured before and after treatment.After 48 days of treatment saftey parameters are repeated.

Trial Locations

Locations (1)

Arignar Anna Govt.Siddha Hospital

🇮🇳

Chennai, TAMIL NADU, India

Arignar Anna Govt.Siddha Hospital
🇮🇳Chennai, TAMIL NADU, India
DR T NATARAJAN
Principal investigator
8939277097
drnataraj88@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.